Abstract
Subclinical hypothyroidism is associated with an increased risk of atherosclerosis. The aim of this study was to investigate the concentration of plasma soluble intercellular adhesion molecule-1 and adiponectin in relation to insulin sensitivity in patients with subclinical hypothyroidism and to estimate if l-thyroxine treatment had an influence on these parameters. 13 women with subclinical hypothyroidism and 14 euthyroid controls were included in the study. A physical examination was conducted, hyperinsulinemic euglycemic clamp and plasma soluble intercellular adhesion molecule-1, adiponectin and lipids profiles were measured at baseline in both groups and in the group with subclinical hypothyroidism the above procedures were performed after l-thyroxine therapy (mean time of treatment 5.0 months) in stable euthyroid state. Insulin sensitivity and adiponectin were not different at baseline in the two studied groups. Plasma soluble intercellular adhesion molecule-1 concentration was significantly higher in the patients with subclinical hypothyroidism (P = 0.011). The comparison of lipids profiles revealed that only LDL-cholesterol concentration was higher (P = 0.011) in the group with subclinical hypothyroidism. After therapy, we observed an improvement of insulin sensitivity (P = 0.012) and a decrease of plasma glucose (P = 0.019) and soluble intercellular adhesion molecule-1 (P = 0.01), whereas adiponectin concentration remained unchanged. We concluded that l-thyroxine treatment in patients with subclinical hypothyroidism might exert a beneficial effect by reducing cardiovascular risk factors.
Similar content being viewed by others
References
M. Danese, P. Ladenson, C. Meinert, E. Powe, Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab. 85, 2993–3001 (2000)
W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clarc, J.G. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickham Survey. Clin. Endocrinol. (Oxf.) 7, 481–493 (1977)
M. Falkenberg, B. Kagedal, A. Norr, Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med. Scand. 214, 361–365 (1983)
J.N. Parle, J.A. Franklyn, K.W. Cross, S.C. Jones, M.C. Sheppard, Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin. Endocrinol. (Oxf) 34, 77–83 (1991)
C.T. Sawin, W.P. Castelli, J.M. Hershman, P. McNamara, P. Bacharach, The aging thyroid. Thyroid deficiency in the Framingham Study. Arch. Intern. Med. 145, 1386–1388 (1985)
N. Caraccio, E. Ferrannini, F. Monzani, Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J. Clin. Endocrinol. Metab. 87, 1533–1538 (2002)
W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clarc, J.G. Evans, E. Young, T. Bird, P.A. Smith, Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin. Endocrinol. (Oxf.) 7, 495–508 (1977)
M.P.J. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clarck, E.J. Grimley, H. Rodgers, F. Tunbridge, E.T. Young, The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6, 155–160 (1996)
D. Liu, F. Jiang, Z. Shan, B. Wang, Y. Lai, Y. Chen, M. Li, H. Liu, C. Li, H. Xue, N. Li, J. Yu, L. Shi, X. Bai, X. Hou, L. Zhu, L. Lu, S. Wang, Q. Xing, W. Teng, A cross-sectional survey of relationship between serum TSH level and blood pressure. J. Hum. Hypertens. 24, 134–138 (2010)
A.E. Hak, H.A.P. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C.M. Witteman, Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 132, 270–278 (2000)
A.W.C. Kung, R.W.C. Pang, E.D. Janus, Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin. Endocrinol. (Oxf) 43, 445–449 (1995)
R. Luboshitzky, A. Aviv, P. Herer, L. Lavie, Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12, 421–425 (2002)
R. Arem, D.A. Escalante, N. Arem, J.D. Morrisett, W. Patsch, Effect of l-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein (a). Metabolism 44, 1559–1563 (1995)
P. Celtour-Rose, C. Theander-Carrillo, C. Asensio, M. Klein, T.J. Visser, A.G. Burger, A.C. Meier, Hypothyroidism in rats decreases peripheral glucose utilization, a defect partially corrected by central leptin infusion. Diabetologia 48, 624–633 (2005)
A. Ross, S.J.L. Bakker, T.P. Links, R.O.B. Gans, B.H.R. Wolffenbuttel, Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92, 491–496 (2007)
A. Tuzcu, M. Bahceci, D. Gokalp, Y. Tuzun, K. Gunes, Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr. J. 58, 89–94 (2005)
S.E. Shoelson, J. Lee, A.B. Goldfine, Inflammation and insulin resistance. J. Clin. Investig. 116, 1793–1801 (2006)
A.D. Paradhan, J.E. Manson, N. Rifai, J.E. Buring, Ridker P.M.: C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA 286, 327–334 (2001)
P.H. Dessein, B.I. Joffe, A.E. Staurx, Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 14, 443–446 (2004)
S. Blankenberg, S. Barbaux, L. Tiret, Adhesion molecules and atherosclerosis. Atherosclerosis 170, 191–203 (2003)
O. Mayer Jr, I. Simon, J. Filipovsky, M. Plaskova, R. Pikner, Hypothyroidism in coronary heart disease and its relation to selected risk factors. Vasc. Health Risk. Mang. 2, 499–506 (2006)
M. Chandran, S.A. Phillips, T. Ciaraldi, R.R. Henry, Adiponectin: more than just another fat cell hormone? Diabetes Care 26, 2442–2450 (2003)
C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, P.A. Tataranni, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930–1935 (2001)
W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)
R.A. DeFronzo, J.A. Tobin, R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237, E214–E223 (1979)
M. Strączkowski, I. Kowalska, A. Nikołajuk, S. Dzienis-Strączkowska, I. Kinalska, M. Baranowski, M. Żendzian-Piotrowska, Z. Brzezinska, J. Gorski, Relationship between insulin sensitivity and sphingomielin siganling pathway in human skeletal muscles. Diabetes 53, 1215–1221 (2004)
A. Handisurya, G. Pacini, A. Tura, A. Gessl, A. Kautzky-Willer, Effects of T4 replacement therapy on glucose metabolism in subject with subclinical (SH) and overt hypothyroidism (OH). Clin. Endocrinol. (Oxf.) 69, 963–969 (2008)
F. Amati, J.J. Dube, M. Stefanovic-Racic, F.G. Toledo, B.H. Goodpaster, Improvements in insulin sensitivity are blunted by subclinical hypothyroidism. Med. Sci. Sports Exerc. 41, 265–269 (2009)
G. Brenta, G. Berg, P. Arias, U. Zago, M. Schnitman, M.L. Muzzio, I. Sinay, L. Schreier, Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to LT(4) treatment. Thyroid 17, 453–460 (2007)
P.F. Teixeira, M.D. Cabral, N.A. Silva, D.V. Soares, V.B. Braulio, A.P. Conto, L.J. Henrignes, A.J. Costa, A. Buescu, M. Vaisman, Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status. Thyroid 19, 443–450 (2009)
E. Maratou, D.J. Hadjidakis, A. Kollias, K. Tsegha, M. Peppa, M. Alvizaki, P. Mitrou, V. Lambadiari, E. Bontati, D. Nizkas, N. Tountas, T. Economopulus, S.A. Raptis, G. Dimitriadis, Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur. J. Endocrinol. 160, 785–790 (2009)
R. Romero, B. Casanova, N. Pulido, A.I. Suarez, E. Rodriguez, Stimulation of glucose transport by thyroid hormone in 3T3–L1 adipocytes: increased abundance of GLUT1 and GLUT4 glucose transporters protein. J. Endocrinol. 164, 187–195 (2000)
S.P. Weinstein, E. O’Boyle, M. Fisher, R.S. Haber, Regulation of GLUT 2 glucose transporter expression in liver by thyroid hormone. Evidence for hormonal regulation of the hepatic glucose transport system. Endocrinology 135, 649–654 (1994)
N. Rodondi, W.P. den Elzen, D.C. Bauer, A.R. Cappola, S. Razvi, J.P. Walsh, B.O. Asvold, G. Iervasi, M. Imaizumi, T.H. Collet, A. Bremner, P. Maisonneuve, J.A. Sgarbi, K.T. Khaw, M.P. Vanderpump, A.B. Newman, J. Cornuz, J.A. Franklyn, R.G. Vestendorp, E. Vittinghoff, J. Gussekloo, Subclinical hypothyroidism and the risk for coronary heart disease and mortality. JAMA 304, 365–374 (2010)
N. Ochs, N. Auer, D.C. Bauer, D. Nanchen, J. Gussekloo, J. Cornuz, N. Rodondi, Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832–845 (2008)
S. Singh, J. Dugal, J. Molnar, F. Maldonado, C.P. Bursano, R. Arora, Impact of subclinical thyroid disorders on coronary heart diseases, cardiovascular and all-cause mortality. Int. J. Cardiol. 125, 41–48 (2008)
S.J. Hwang, C.M. Ballantyne, A.R. Sharrett, L.C. Smith, C.E. Davis, A.M. Gotto Jr, E. Boerwinkle, Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 16, 4219–4225 (1997)
L.E. Rohde, R.T. Lee, J. Rivero, M. Jamacochian, L.H. Arroyo, W. Briggs, N. Rifai, P. Libby, M.A. Creager, P.M. Ridker, Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 18, 1765–1770 (1998)
F. Monzani, N. Caraccio, M. Kozakowa, A. Dardano, F. Vittone, A. Viridis, S. Taddei, C. Palombo, E. Ferrannini, Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J. Clin. Endocrinol. Metab. 89, 2099–2106 (2004)
H. Fukazawa, K. Yoshida, N. Kaise, Y. Kiso, N. Sayama, K. Mori, K. Kikuchi, Y. Aizawa, A. Rikimaru, K. Abe, Intercellular adhesion molecule-1 (ICAM-1) in the sera of patients with Graves’ disease: correlation with disease activity and treatment status. Thyroid 5, 373–377 (1995)
M. Ozata, E. Bolu, A. Sengul, H.I. Altinsoy, M. Turan, A. Corakci, A. Hacibektasoglu, M.A. Gundogan, Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves’ disease with or without ophthalmopathy. Endocr. J. 43, 517–525 (1996)
F. Santini, A. Marsili, R. Mammoli, G. Valeriano, C. Scartabelli, M. Pelosini, R. Giannetti, P. Centoni, A. Vitti, A. Pinchera, Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J. Endocrinol. Investig. 27, RC5–RC7 (2004)
P. Iglesias, P. Alvarez Fidalgo, R. Codoceo, J.J. Diez, Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin. Endocrinol. (Oxf) 59, 621–629 (2003)
A.E. Altinova, F.B. Toruner, M. Aturk, N. Bukan, N. Cakir, G. Ayvaz, M. Arslan, Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin. Endocrinol. (Oxf) 65, 530–535 (2006)
B. Biondi, D. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocrine Rev. 29, 76–131 (2008)
Acknowledgements
This work was supported by a grant form the Medical University of Bialystok, Poland No 3-50951.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kowalska, I., Borawski, J., Nikołajuk, A. et al. Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine 40, 95–101 (2011). https://doi.org/10.1007/s12020-011-9446-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9446-5